N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide : An amino acid amide obtained by the formal condensation of 2,6-dimethylaniline with N-(3,5-dimethylphenyl)glycine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 762947 |
| CHEMBL ID | 1418747 |
| CHEBI ID | 75364 |
| SCHEMBL ID | 7945872 |
| Synonym |
|---|
| CBDIVE_016081 |
| CBCHROMO1_000101 |
| PROBES1_000171 |
| n~1~-(2,6-dimethylphenyl)-n~2~-(3,5-dimethylphenyl)glycinamide |
| smr000069153 |
| MLS000060925 |
| OPREA1_549117 |
| PROBES2_000344 |
| 2-(3,5-dimethylanilino)-n-(2,6-dimethylphenyl)acetamide |
| CHEBI:75364 , |
| n-(2,6-dimethylphenyl)-n(2)-(3,5-dimethylphenyl)glycinamide |
| n(1)-(2,6-dimethylphenyl)-n(2)-(3,5-dimethylphenyl)glycinamide |
| n-(2,6-dimethylphenyl)-2-[(3,5-dimethylphenyl)amino]ethanamide |
| HMS2417L14 |
| AB00075399-01 |
| SCHEMBL7945872 |
| cambridge id 5213008 |
| CHEMBL1418747 |
| Q27145250 |
| Class | Description |
|---|---|
| glycine derivative | A proteinogenic amino acid derivative resulting from reaction of glycine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
| amino acid amide | An amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 28.1838 | 0.0184 | 6.8060 | 14.1254 | AID624417 |
| TDP1 protein | Homo sapiens (human) | Potency | 29.0929 | 0.0008 | 11.3822 | 44.6684 | AID686978 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 35.4813 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 3.9811 | 0.0013 | 18.0743 | 39.8107 | AID926 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 35.4813 | 0.0006 | 18.4198 | 1,122.0200 | AID1688 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 100.0000 | 0.0501 | 27.0736 | 89.1251 | AID588590 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 11.2202 | 1.9953 | 25.5327 | 50.1187 | AID624287 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| negative regulation of inflammatory response to antigenic stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| renal water homeostasis | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| regulation of insulin secretion | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| cellular response to glucagon stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| G protein activity | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| adenylate cyclase activator activity | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| plasma membrane | Guanine nucleotide-binding protein G | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| AID1159537 | qHTS screening for TAG (triacylglycerol) accumulators in algae | 2017 | Plant physiology, Aug, Volume: 174, Issue:4 | Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| levoplast | [no description available] | medium | 1 | 0 | C-nitro compound | |
| hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite; uremic toxin |
| xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
| atrolactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | |
| etofylline | [no description available] | medium | 1 | 0 | oxopurine | |
| n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid; tryptophan derivative | metabolite |
| ethacridine | [no description available] | medium | 1 | 0 | acridines | |
| altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
| 2,5-di-tert-butylhydroquinone | [no description available] | medium | 1 | 0 | hydroquinones | |
| cx546 | [no description available] | medium | 1 | 0 | ||
| diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
| diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
| ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
| ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether; isoflavones | bone density conservation agent |
| mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
| nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator |
| piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
| prometone | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methoxy-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
| propanil | [no description available] | medium | 1 | 0 | anilide; dichlorobenzene | herbicide |
| sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
| sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
| sulfathiazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
| testosterone | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
| 2-hydroxybenzylbenzimidazole | [no description available] | medium | 1 | 0 | ||
| etimizol | [no description available] | medium | 1 | 0 | ||
| nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
| bis(4-hydroxyphenyl)sulfone | [no description available] | medium | 1 | 0 | bisphenol; sulfone | endocrine disruptor; metabolite |
| 8-hydroxyquinoline-5-sulfonic acid | [no description available] | medium | 1 | 0 | ||
| salicylanilide | [no description available] | medium | 1 | 0 | benzanilide fungicide; salicylamides; salicylanilides | |
| 2-phenylbutyric acid | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | human xenobiotic metabolite |
| 4,4'-dimethoxybenzophenone | [no description available] | medium | 1 | 0 | ||
| 6-phenyl-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | ||
| quinaldic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite |
| N-(2-methoxyphenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; methoxybenzenes | |
| fast red b | [no description available] | medium | 1 | 0 | ||
| methylenebis(chloroaniline) | [no description available] | medium | 1 | 0 | chloroaniline | metabolite |
| di-(4-aminophenyl)ether | [no description available] | medium | 1 | 0 | aromatic ether | |
| diphenylguanidine | [no description available] | medium | 1 | 0 | guanidines | allergen |
| 4-Anilino-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
| etryptamine | [no description available] | medium | 1 | 0 | indoles | |
| sulfacetamide | [no description available] | medium | 1 | 0 | ||
| cinchophen | [no description available] | medium | 1 | 0 | quinolines | |
| 2-aminobenzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles | |
| carzenide | [no description available] | medium | 1 | 0 | sulfonamide | |
| nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
| n-(2-cyanoethyl)-2-phenylethylamine | [no description available] | medium | 1 | 0 | ||
| cyclooctane | [no description available] | medium | 1 | 0 | ||
| triphenyltetrazolium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | dye; indicator |
| 2,7-diacetylaminofluorene | [no description available] | medium | 1 | 0 | ||
| 3,4-pyridinedicarboxylic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | |
| 4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| tropic acid | [no description available] | medium | 1 | 0 | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite |
| 8-hydroxy-7-iodo-5-quinolinesulfonic acid | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| 1-acetylisatin | [no description available] | medium | 1 | 0 | indoledione | |
| 4-cumylphenol | [no description available] | medium | 1 | 0 | diarylmethane | |
| 5-methylisatin | [no description available] | medium | 1 | 0 | ||
| 2-hydrazinobenzothiazole | [no description available] | medium | 1 | 0 | ||
| 1,2,3-trimethoxybenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | plant metabolite |
| 2-amino-5-chlorobenzophenone | [no description available] | medium | 1 | 0 | ||
| diphenamid | [no description available] | medium | 1 | 0 | diarylmethane | |
| 4-(4-nitrobenzyl)pyridine | [no description available] | medium | 1 | 0 | ||
| 5-methyl-3-phenylisoxazole-4-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| 2-acetylbenzofuran | [no description available] | medium | 1 | 0 | ||
| pyrazon | [no description available] | medium | 1 | 0 | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic |
| 2-amino-5-nitrobenzophenone | [no description available] | medium | 1 | 0 | ||
| (4-tert-Butyl-phenoxy)-acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
| lenacil | [no description available] | medium | 1 | 0 | cyclopentapyrimidine | agrochemical; environmental contaminant; herbicide; xenobiotic |
| chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
| 2-amino-2',5-dichlorobenzophenone | [no description available] | medium | 1 | 0 | ||
| 2-(2'-hydroxyphenyl)benzimidazole | [no description available] | medium | 1 | 0 | ||
| 4-phthalimidobutyric acid | [no description available] | medium | 1 | 0 | ||
| azabutyrone | [no description available] | medium | 1 | 0 | ||
| 2-(2-hydroxyphenyl)benzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles; phenols | geroprotector |
| 4,5-dichlorocatechol | [no description available] | medium | 1 | 0 | ||
| n-butylbenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | neurotoxin; plant metabolite |
| 3-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | human xenobiotic metabolite; marine xenobiotic metabolite |
| 2-(2-hydroxyethylmercapto)benzothiazole | [no description available] | medium | 1 | 0 | ||
| carboxin | [no description available] | medium | 1 | 0 | anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
| meturin | [no description available] | medium | 1 | 0 | ||
| 2-bromo-N-phenylbenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-chlorohippuric acid | [no description available] | medium | 1 | 0 | ||
| 4-chlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; monochlorobenzenes | phenoxy herbicide |
| 2,5-dichloro-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | ||
| metribuzin | [no description available] | medium | 1 | 0 | 1,2,4-triazines; cyclic ketone; organic sulfide | agrochemical; environmental contaminant; herbicide; xenobiotic |
| 2,5-dimethyl-3-furancarboxanilide | [no description available] | medium | 1 | 0 | ||
| moricizine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
| 2-benzimidazolylguanidine | [no description available] | medium | 1 | 0 | aminoimidazole | |
| diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; monochlorobenzenes | insect sterilant |
| pentafluorobenzoyl-n-phenylethylamine | [no description available] | medium | 1 | 0 | ||
| thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
| phenthiazamine | [no description available] | medium | 1 | 0 | ||
| 5,5-diphenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
| 3-acetamidobenzoic acid | [no description available] | medium | 1 | 0 | ||
| dazoxiben hydrochloride | [no description available] | medium | 1 | 0 | ||
| succinylsulfanilamide | [no description available] | medium | 1 | 0 | ||
| benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin; plant metabolite |
| ciprofloxacin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
| src-820 r | [no description available] | medium | 1 | 0 | ||
| n(4)-acetylsulfadiazine | [no description available] | medium | 1 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| 4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | [no description available] | medium | 1 | 0 | ||
| formetamide | [no description available] | medium | 1 | 0 | ||
| isbufylline | [no description available] | medium | 1 | 0 | ||
| phenylacetylglycine | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite |
| N-benzoylanthranilic acid | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| butinoline | [no description available] | medium | 1 | 0 | diarylmethane | |
| n-(2-carboxyphenyl)glycine | [no description available] | medium | 1 | 0 | ||
| n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | ||
| n-benzoylpiperidine | [no description available] | medium | 1 | 0 | benzamides; N-acylpiperidine | |
| 2-phenylcyclopropanecarboxylic acid | [no description available] | medium | 1 | 0 | ||
| n-demethylantipyrine | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
| 2-amino-5-bromopyridine | [no description available] | medium | 1 | 0 | ||
| n-benzoylalanine, (dl-ala)-isomer | [no description available] | medium | 1 | 0 | alanine derivative; N-acyl-amino acid | metabolite |
| bicinchoninic acid | [no description available] | medium | 1 | 0 | ||
| betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| benzoylpropionic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid | hapten |
| Evoxine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | harmala alkaloid | |
| N-Benzylphthalimide | [no description available] | medium | 1 | 0 | isoindoles | |
| pyromellitic diimide | [no description available] | medium | 1 | 0 | ||
| 4'-bromosalicylanilide | [no description available] | medium | 1 | 0 | ||
| 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [no description available] | medium | 1 | 0 | bisphenol | |
| terephthalamide | [no description available] | medium | 1 | 0 | benzenedicarboxamide | |
| 3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | [no description available] | medium | 1 | 0 | ||
| 2-nitrophenylacetic acid | [no description available] | medium | 1 | 0 | C-nitro compound; phenylacetic acids | |
| onychine | [no description available] | medium | 1 | 0 | ||
| 4'-methoxyflavone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
| 1,3-diphenyl-2-aminopropane | [no description available] | medium | 1 | 0 | ||
| 2,2-diphenylpropionic acid | [no description available] | medium | 1 | 0 | ||
| 3,4-dimethoxyphenylacetamide | [no description available] | medium | 1 | 0 | ||
| 2-amino-5-bromobenzoic acid | [no description available] | medium | 1 | 0 | ||
| 2-(1H-benzimidazol-2-yl)aniline | [no description available] | medium | 1 | 0 | benzimidazoles; primary arylamine; substituted aniline | geroprotector |
| N-Acetylhomoveratrylamine | [no description available] | medium | 1 | 0 | acetamides | |
| 2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| 4-nitrophenyl dimethylcarbamate | [no description available] | medium | 1 | 0 | ||
| 8-(4-tolylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | sulfonamide | |
| 5-methoxyindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | indoles | |
| 2-oxo-1,2-dihydroquinoline-4-carboxylic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | |
| 6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | [no description available] | medium | 1 | 0 | beta-carbolines | |
| pd 147953 | [no description available] | medium | 1 | 0 | ||
| fenozan | [no description available] | medium | 1 | 0 | ||
| 5-phenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
| diethylpropion hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | appetite depressant |
| 1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | [no description available] | medium | 1 | 0 | ||
| beta-hydroxyphenylalanine | [no description available] | medium | 1 | 0 | ||
| 3-(n-salicyloyl)amino-1,2,4-triazole | [no description available] | medium | 1 | 0 | ||
| 7-chloro-4-aminoquinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
| acridine-9-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| 1-phenazinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; monocarboxylic acid; phenazines | antifungal agent; antimicrobial agent; bacterial metabolite |
| 4,5-diphenyl-1,5-dihydroimidazol-2-one | [no description available] | medium | 1 | 0 | stilbenoid | |
| 2-hydroxy-1,2-bis(methoxyphenyl)ethanone | [no description available] | medium | 1 | 0 | ||
| 4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-n-butylaminobenzoic acid | [no description available] | medium | 1 | 0 | aromatic amino acid | |
| fluoren-9-ol | [no description available] | medium | 1 | 0 | ||
| 1-(2-carboxyethyl)uracil | [no description available] | medium | 1 | 0 | ||
| 1-benzylindole | [no description available] | medium | 1 | 0 | ||
| 2,3-bis(2-pyridinyl)quinoxaline | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | [no description available] | medium | 1 | 0 | dichlorobenzene; hydroxybiphenyls | |
| 5-nitro-2-(1-piperidinyl)pyridine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-amino-5,7-dimethyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | ||
| 5-benzyloxytryptophan | [no description available] | medium | 1 | 0 | ||
| 2,5-diethoxy-4-morpholinoaniline | [no description available] | medium | 1 | 0 | ||
| 3-hydroxy-3-phenacyloxindole | [no description available] | medium | 1 | 0 | ||
| carbobenzoxyphenylalanine, (dl-phe)-isomer | [no description available] | medium | 1 | 0 | ||
| gamma-fagarine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
| 4-fluorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| emoxypine succinate | [no description available] | medium | 1 | 0 | ||
| n-carbamyltryptophan | [no description available] | medium | 1 | 0 | ||
| 2,4,6-trimethoxyacetophenone | [no description available] | medium | 1 | 0 | ||
| 1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | [no description available] | medium | 1 | 0 | ||
| 4-methyoxybenzoyl-n-glycine | [no description available] | medium | 1 | 0 | N-acylglycine | |
| 5-ethoxy-2-ethylmercaptobenzimidazole | [no description available] | medium | 1 | 0 | ||
| 5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | [no description available] | medium | 1 | 0 | ||
| n-phenyliminodiacetic acid | [no description available] | medium | 1 | 0 | ||
| teomorfolin | [no description available] | medium | 1 | 0 | ||
| 1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | [no description available] | medium | 1 | 0 | benzodioxoles | |
| n-(aminocarbonyl)-2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
| 3-hydroxy-2-quinoxalinepropionic acid | [no description available] | medium | 1 | 0 | ||
| 8-(methylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
| n(4)-acetylsulfamonomethoxine | [no description available] | medium | 1 | 0 | ||
| 8-(4-benzenesulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
| methindione | [no description available] | medium | 1 | 0 | ||
| 3,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | ||
| gamma-propanol | [no description available] | medium | 1 | 0 | ||
| 2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | [no description available] | medium | 1 | 0 | benzenes; nitrile | |
| isonicotinylamide gaba | [no description available] | medium | 1 | 0 | ||
| 5-fluorotryptamine monohydrochloride | [no description available] | medium | 1 | 0 | ||
| 4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | [no description available] | medium | 1 | 0 | ||
| 3-(hydroxyacetyl)indole | [no description available] | medium | 1 | 0 | indoles | |
| n-(4-aminophenylsulfonyl)morpholine | [no description available] | medium | 1 | 0 | ||
| 1H-indol-3-yl-(4-methoxyphenyl)methanone | [no description available] | medium | 1 | 0 | N-acylindole | |
| 2-amino-5-phenyl-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | ||
| N-(1-phenylethyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; secondary carboxamide | |
| alpha-(trichloromethyl)-4-pyridineethanol | [no description available] | medium | 1 | 0 | pyridines | |
| ml 204 | [no description available] | medium | 1 | 0 | ||
| eudesmin | [no description available] | medium | 1 | 0 | ||
| 2-amino-4-methyl-3-nitropyridine | [no description available] | medium | 1 | 0 | ||
| 4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | [no description available] | medium | 1 | 0 | ||
| n-acetylhistidine | [no description available] | medium | 1 | 0 | histidine derivative; N-acetyl-amino acid | |
| 1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | acetamides | |
| 1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 4-methoxyxanthone | [no description available] | medium | 1 | 0 | ||
| N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 1-phenylindolin-2-one | [no description available] | medium | 1 | 0 | ||
| 1-(benzenesulfonyl)indole | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | [no description available] | medium | 1 | 0 | dihydropyridine | |
| pifithrin mu | [no description available] | medium | 1 | 0 | benzenes | |
| 2-benzyloxybenzaldehyde | [no description available] | medium | 1 | 0 | ||
| 2-guanidine-4-methylquinazoline | [no description available] | medium | 1 | 0 | ||
| N-phenylcarbamic acid 2-phenoxyethyl ester | [no description available] | medium | 1 | 0 | carbamate ester | |
| 3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| mequindox | [no description available] | medium | 1 | 0 | ||
| N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
| Girgensonine | [no description available] | medium | 1 | 0 | nitrile | |
| Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(2-oxazolo[4,5-b]pyridinyl)aniline | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | [no description available] | medium | 1 | 0 | benzoxazole | |
| 3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | [no description available] | medium | 1 | 0 | pyridazines | |
| 3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | [no description available] | medium | 1 | 0 | substituted aniline | |
| 1-phenyl-4-pyrazolol | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 3-benzamido-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(1H-indol-3-ylthio)acetic acid | [no description available] | medium | 1 | 0 | indoles | |
| 3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| 3-Methylbenzofuran-2-carboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(3,4-dimethoxyphenyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
| 1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| 2-phenylindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | ||
| 4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | [no description available] | medium | 1 | 0 | pyrimidines | |
| 7-methoxyisoflavone | [no description available] | medium | 1 | 0 | 7-methoxyisoflavones | |
| LSM-32392 | [no description available] | medium | 1 | 0 | monoterpenoid | |
| N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-acetamido-5-chloro-2-benzofurancarboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| [4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
| 4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| haplamine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
| 5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | [no description available] | medium | 1 | 0 | triazoles | |
| 2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | [no description available] | medium | 1 | 0 | pyridines; pyrrolidines; quinazolines | |
| scp 1 | [no description available] | medium | 1 | 0 | ||
| N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-[4-(diethylamino)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| N-(2-furanylmethyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | [no description available] | medium | 1 | 0 | aromatic amine; thiadiazoles | |
| te 5 | [no description available] | medium | 1 | 0 | ||
| 2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | ureas | |
| N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 6-methylflavone | [no description available] | medium | 1 | 0 | ||
| 2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-chloro-N-(2-phenylethyl)benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| tioxazafen | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole; thiophenes | agrochemical; nematicide |
| N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| brd32048 | [no description available] | medium | 1 | 0 | methoxybenzenes; substituted aniline | |
| 2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | [no description available] | medium | 1 | 0 | imidazoles | |
| 5-(2-phenyl-4-triazolyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | triazoles | |
| N-cyclohexyl-2,3-dihydroindole-1-carboxamide | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
| 4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide; benzenes; thienopyrimidine | |
| 2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | |
| 1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | [no description available] | medium | 1 | 0 | indolecarboxamide | |
| N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(1H-benzimidazol-2-yl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| N-(4-methoxyphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 2-(9h-xanthen-9-yl)-malonic acid | [no description available] | medium | 1 | 0 | xanthenes | |
| 1-(1,3-benzothiazol-2-yl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | [no description available] | medium | 1 | 0 | imidazoles | |
| N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-bromo-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | medium | 1 | 0 | indoles | |
| N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | triazoles | |
| N,N-dimethyl-N'-p-tolylsulfamide | [no description available] | medium | 1 | 0 | sulfamides | marine xenobiotic metabolite |
| 2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | ||
| 2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 1-cyclohexyl-3-(2-phenylethyl)urea | [no description available] | medium | 1 | 0 | benzenes | |
| 1-(3,5-dichlorophenyl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-(cyclohexylmethyl)-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-phenethyl-2-furamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| paromomycin sulfate | [no description available] | medium | 1 | 0 | ||
| N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
| 2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| vu0099704 | [no description available] | medium | 1 | 0 | ||
| 3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
| 1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | medium | 1 | 0 | triazoles | |
| 2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | [no description available] | medium | 1 | 0 | ||
| (3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 2-fluoro-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
| 1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | [no description available] | medium | 1 | 0 | carbonyl compound; thiol | |
| GS4012 free base | [no description available] | medium | 1 | 0 | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator |
| N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| 1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-Piperidinobenzoic acid | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | [no description available] | medium | 1 | 0 | benzodioxine | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | ||
| 8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2'-nitroflavone | [no description available] | medium | 1 | 0 | ||
| N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | [no description available] | medium | 1 | 0 | aminoquinoline | |
| 1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | [no description available] | medium | 1 | 0 | aromatic compound | |
| vrt 532 | [no description available] | medium | 1 | 0 | ||
| 4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | [no description available] | medium | 1 | 0 | piperazines | |
| 1-piperonylpiperidine | [no description available] | medium | 1 | 0 | ||
| 2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazolopyrimidine | |
| N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | [no description available] | medium | 1 | 0 | imidazoles | |
| 2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | [no description available] | medium | 1 | 0 | benzoxazole | |
| 1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | [no description available] | medium | 1 | 0 | N-acylglycine | |
| (4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
| 2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | aromatic ether; C-nitro compound | |
| 3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 2-(dimethylsulfamoylamino)-9H-fluorene | [no description available] | medium | 1 | 0 | fluorenes | |
| 4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | medium | 1 | 0 | quinolines | |
| 2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | [no description available] | medium | 1 | 0 | arenecarbaldehyde | |
| 2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | [no description available] | medium | 1 | 0 | triazoles | |
| N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | organofluorine compound | |
| 4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | [no description available] | medium | 1 | 0 | phthalazines | |
| N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | phthalimides | |
| 6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | pyridines | |
| 2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| (2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | [no description available] | medium | 1 | 0 | carbazoles | |
| N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | [no description available] | medium | 1 | 0 | primary carboxamide; pyrazines; secondary carboxamide | |
| N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzodioxoles | |
| 1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | [no description available] | medium | 1 | 0 | benzodioxine | |
| 8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 1-[2-(2-chlorophenoxy)ethyl]benzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | [no description available] | medium | 1 | 0 | triazolopyridazine | |
| N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| oncrasin-1 | [no description available] | medium | 1 | 0 | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer |
| N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-anilinophenyl)-2-methylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-(2-fluorophenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| 1-[(Phenylthio)acetyl]piperidine | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| 4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | medium | 1 | 0 | quinolines | |
| 2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | [no description available] | medium | 1 | 0 | naphthofuran | |
| 5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| 1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-propylsulfonyl-4-(2-pyridinyl)piperazine | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 2-(2-phenylethylthio)-3-pyridinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
| 2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | [no description available] | medium | 1 | 0 | thiazoles | |
| 1-cyclohexyl-3-(3-ethylphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| n-phenylpiracetam | [no description available] | medium | 1 | 0 | ||
| 2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | [no description available] | medium | 1 | 0 | biphenyls | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | [no description available] | medium | 1 | 0 | isoquinolines | |
| 5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1,4-bis(thiophen-2-ylsulfonyl)piperazine | [no description available] | medium | 1 | 0 | N-sulfonylpiperazine; thiophenes | |
| 2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | [no description available] | medium | 1 | 0 | ||
| 2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | [no description available] | medium | 1 | 0 | quinazolines | |
| 1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | [no description available] | medium | 1 | 0 | morpholines | |
| ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | [no description available] | medium | 1 | 0 | carbamate ester; sulfonamide | |
| LSM-4563 | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 1 | 0 | quinolines | |
| N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | tetrazoles | |
| 2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
| 2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | [no description available] | medium | 1 | 0 | thiazolopyrimidine | |
| 3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | |
| N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| stk295900 | [no description available] | medium | 1 | 0 | ||
| 1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyridazines; ring assembly | |
| 1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | [no description available] | medium | 1 | 0 | ureas | |
| N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | [no description available] | medium | 1 | 0 | phthalazines | |
| SMER 28 | [no description available] | medium | 1 | 0 | organobromine compound; quinazolines; secondary amino compound | autophagy inducer |
| N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | [no description available] | medium | 1 | 0 | morpholines | |
| 4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | medium | 1 | 0 | aromatic ether | |
| 4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-phenylpropyl)methanesulfonamide | [no description available] | medium | 1 | 0 | benzenes | |
| 4-acetamido-N-(2-methoxyethyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | medium | 1 | 0 | quinolines | |
| 5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | medium | 1 | 0 | aromatic ether | |
| 3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | [no description available] | medium | 1 | 0 | aralkylamine | |
| 4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | piperazinecarboxylic acid | |
| 2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | medium | 1 | 0 | aromatic ether | |
| N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | biphenyls | |
| 5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | ||
| 2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| Methyl(2-furoylamino)acetic acid | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
| 5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | [no description available] | medium | 1 | 0 | amino acid amide | |
| 2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | medium | 1 | 0 | ||
| 1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | medium | 1 | 0 | acetamides | |
| 2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
| (3,5-Dimethyl-1-adamantyl)amine nitrate | [no description available] | medium | 1 | 0 | nitrates | |
| 1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
| 4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| 3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
| 2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | medium | 1 | 0 | benzodioxine | |
| 2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | [no description available] | medium | 1 | 0 | aromatic compound | |
| 2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | medium | 1 | 0 | organochlorine compound; pyranopyrazole | |
| 1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
| 4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
| 1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | anilide | |
| 4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
| [3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | [no description available] | medium | 1 | 0 | aromatic amide; thiophenes | |
| [4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | piperazines | |
| N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
| 4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | [no description available] | medium | 1 | 0 | piperazines | |
| 5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
| 1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
| 6,3',4'-Trimethoxyflavanone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
| 1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | medium | 1 | 0 | aromatic ether | |
| 5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
| 2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| [4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| LSM-25805 | [no description available] | medium | 1 | 0 | isoindoles | |
| 4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| 3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | [no description available] | medium | 1 | 0 | 1-benzothiophenes | |
| nsc 727447 | [no description available] | medium | 1 | 0 | ||
| 2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | medium | 1 | 0 | C-nitro compound; thiazoles | |
| 7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | medium | 1 | 0 | quinolines | |
| N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | [no description available] | medium | 1 | 0 | ||
| N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; thiazoles | |
| ex 527 | [no description available] | medium | 1 | 0 | carbazoles; monocarboxylic acid amide; organochlorine compound | |
| 3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | medium | 1 | 0 | indoles | |
| 4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | [no description available] | medium | 1 | 0 | phenylpyridine | |
| 3-methylharman | [no description available] | medium | 1 | 0 | ||
| 1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | ||
| sildenafil | [no description available] | medium | 1 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
| 2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | ||
| n(4)-desoxychlordiazepoxide | [no description available] | medium | 1 | 0 | ||
| 2-amino-3-hydroxyphenazine | [no description available] | medium | 1 | 0 | ||
| 2-styrylquinazolin-4(3h)-one | [no description available] | medium | 1 | 0 | ||
| 2-amino-5-iodo-6-phenyl-4-pyrimidinone | [no description available] | medium | 1 | 0 | ||
| quininib | [no description available] | medium | 1 | 0 | phenols; styrylquinoline | angiogenesis inhibitor |
| bropirimine | [no description available] | medium | 1 | 0 | pyrimidines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| betaine | [no description available] | low | 0 | 0 | amino-acid betaine; glycine derivative | fundamental metabolite |
| creatine | [no description available] | low | 0 | 0 | glycine derivative; guanidines; zwitterion | geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical |
| glyphosate | [no description available] | low | 0 | 0 | glycine derivative; phosphonic acid | agrochemical; EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor; herbicide |
| (n-(p-cyanophenyl)-n'-(diphenylmethyl)guanidine)acetic acid | [no description available] | low | 0 | 0 | glycine derivative; guanidines | epitope; sweetening agent |
| iminodiacetic acid | [no description available] | low | 0 | 0 | amino dicarboxylic acid; glycine derivative; non-proteinogenic alpha-amino acid | chelator |
| methyl hippurate | [no description available] | low | 0 | 0 | glycine derivative; methyl ester | metabolite |
| glyphosphine | [no description available] | low | 0 | 0 | glycine derivative; phosphonic acids; tertiary amino compound | plant growth retardant |
| edda | [no description available] | low | 0 | 0 | amino dicarboxylic acid; ethylenediamine derivative; glycine derivative; polyamino carboxylic acid | bacterial xenobiotic metabolite; chelator |
| glycine amide | [no description available] | low | 0 | 0 | amino acid amide; glycine derivative | |
| vinylglycine | [no description available] | low | 0 | 0 | glycine derivative; L-alpha-amino acid zwitterion; non-proteinogenic L-alpha-amino acid | EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor |
| dimethyloxalylglycine | [no description available] | low | 0 | 0 | glycine derivative; methyl ester; secondary carboxamide | EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor; neuroprotective agent |
| 5-(carboxymethylaminomethyl)-2-thiouridine | [no description available] | low | 0 | 0 | glycine derivative; thiouridine | Mycoplasma genitalium metabolite |
| fructosyl-glycine | [no description available] | low | 0 | 0 | fructosamine; glycine derivative; glyco-amino acid | human metabolite |
| N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | [no description available] | low | 0 | 0 | D-leucine derivative; dichlorobenzene; furoic acid; glycine derivative; guanidines; pyrazolylpiperidine | |
| osu 03012 | [no description available] | low | 0 | 0 | antibiotic antifungal drug; aromatic amide; glycine derivative; organofluorine compound; phenanthrenes; pyrazoles | antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
| ixazomib | [no description available] | low | 0 | 0 | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor |
| midodrine | [no description available] | low | 0 | 0 | amino acid amide; aromatic ether; secondary alcohol | alpha-adrenergic agonist; prodrug; sympathomimetic agent; vasoconstrictor agent |
| oxethazaine | [no description available] | low | 0 | 0 | amino acid amide | |
| prilocaine | [no description available] | low | 0 | 0 | amino acid amide; monocarboxylic acid amide | anticonvulsant; local anaesthetic |
| qx-222 | [no description available] | low | 0 | 0 | amino acid amide | |
| ambucetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| trimecaine | [no description available] | low | 0 | 0 | amino acid amide | |
| [2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-(phenylmethyl)ammonium | [no description available] | low | 0 | 0 | amino acid amide | |
| Phenylacetylglycine dimethylamide | [no description available] | low | 0 | 0 | amino acid amide | |
| pyrrocaine | [no description available] | low | 0 | 0 | amino acid amide | |
| monoethylglycinexylidide | [no description available] | low | 0 | 0 | amino acid amide | drug metabolite |
| etidocaine | [no description available] | low | 0 | 0 | amino acid amide | local anaesthetic |
| lidofenin | [no description available] | low | 0 | 0 | amino acid amide | |
| mebrofenin | [no description available] | low | 0 | 0 | amino acid amide | |
| calpeptin | [no description available] | low | 0 | 0 | amino acid amide | |
| glycinexylidide | [no description available] | low | 0 | 0 | amino acid amide | drug metabolite |
| N1-(4-nitrophenyl)-2-amino-3-(benzylthio)propanamide | [no description available] | low | 0 | 0 | amino acid amide | |
| leucine-beta-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-leucine derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| phenylalanine-beta-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-phenylalanine derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| prolinamide | [no description available] | low | 0 | 0 | amino acid amide; L-proline derivative; pyrrolidinecarboxamide | |
| 2',6'-pipecoloxylidide | [no description available] | low | 0 | 0 | amino acid amide | |
| safinamide | [no description available] | low | 0 | 0 | amino acid amide | |
| tyrosinamide | [no description available] | low | 0 | 0 | amino acid amide; L-tyrosine derivative | |
| arginine beta-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-arginine derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| 3-hydroxylidocaine | [no description available] | low | 0 | 0 | amino acid amide | |
| isoglutamine | [no description available] | low | 0 | 0 | amino acid amide; glutamic acid derivative | |
| gamma-glutamyl-2-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-glutamic acid derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| 2-[carboxymethyl-[2-(2,6-diethylanilino)-2-oxoethyl]amino]acetic acid | [no description available] | low | 0 | 0 | amino acid amide | |
| beta-alanine amide | [no description available] | low | 0 | 0 | amino acid amide | |
| ns 105 | [no description available] | low | 0 | 0 | amino acid amide | |
| bortezomib | [no description available] | low | 0 | 0 | amino acid amide; L-phenylalanine derivative; pyrazines | antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor |
| tryptophanamide | [no description available] | low | 0 | 0 | amino acid amide; tryptophan derivative | human metabolite |
| phenylalanine amide | [no description available] | low | 0 | 0 | amino acid amide; phenylalanine derivative | |
| argininamide | [no description available] | low | 0 | 0 | amino acid amide; guanidines; L-arginine derivative | |
| a 80987 | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(1,3-benzodioxol-5-ylamino)-N-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[4-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-2-thiazolyl]-2-(4-morpholinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(1,3-benzodioxol-5-yl)-2-[4-(4-phenyl-2-thiazolyl)-1-piperazinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-(1H-benzimidazol-2-yl)ethyl]-2-[4-(5-fluoro-1-benzotriazolyl)-1-piperidinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(butan-2-ylamino)-N-[4-[5-[[2-(butan-2-ylamino)-1-oxoethyl]amino]-1,3-benzoxazol-2-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[5-[[2-(4-methylanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-(4-morpholinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(butylamino)-N-[4-[5-[[2-(butylamino)-1-oxoethyl]amino]-1,3-benzoxazol-2-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 5-bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| 3-[(3aR,6aS)-6'-chloro-5-(4-chlorophenyl)-7'-methyl-2',4,6-trioxo-1-spiro[1,2,3a,6a-tetrahydropyrrolo[3,4-c]pyrrole-3,3'-1H-indole]yl]propanamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(cyclohexylamino)-N-(4-ethylphenyl)-2-sulfanylideneacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| L-histidine 2-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-histidine derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| 2-anilino-N-(4-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(4-methyl-1-piperazinyl)-N-(5-thiophen-2-yl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(4-fluorophenyl)-2-[4-[oxo(1-piperidinyl)methyl]-1-piperazinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-[(4-tert-butylphenyl)sulfonylamino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[2-(4-morpholinyl)-1-oxoethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| 4-(5-methyl-2-furanyl)-2-[[2-(4-morpholinyl)-1-oxoethyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[4-[5-(trifluoromethyl)-1-benzotriazolyl]-1-piperidinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N'-(4-phenyl-2-thiazolyl)-N-(2-pyridinylmethyl)oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N'-[(4-chlorophenyl)methyl]-N-[2-(3,4-dimethoxyphenyl)ethyl]oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-chlorophenyl)-2-(4-methyl-1-piperidinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 3-methyl-5-[[1-oxo-2-(2-pyridinylmethylamino)ethyl]amino]thiophene-2,4-dicarboxylic acid diethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[2-(difluoromethoxy)anilino]-1-(2,3-dihydroindol-1-yl)ethanone | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(1-azepanyl)-N-[4-(dimethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(2,3-dimethylanilino)-N-(2,3-dimethylphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-cyano-2-thiophenyl)-2-[4-(2,5-dimethylphenyl)sulfonyl-1-piperazinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[4-amino-6-(2-methylanilino)-1,3,5-triazin-2-yl]methyl-methylamino]-N-(2-ethylphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(4-methyl-1-piperidinyl)-N-[2-(phenylthio)phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(2-bromophenyl)-2-[[2-(2,6-dimethylanilino)-2-oxoethyl]-methylamino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(4-cyano-1-phenyl-1H-pyrazol-5-yl)-2-(4-methylpiperazino)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N'-[4-(1-adamantyl)-2-thiazolyl]-N-[(4-fluorophenyl)methyl]oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-chloro-4-methylphenyl)-2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(4-nitrophenyl)-2-(1-pyrrolidinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(benzenesulfonamido)-N-[(2-methoxyphenyl)methyl]propanamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-cycloheptyl-2-(cyclohexylamino)-2-sulfanylideneacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 6-methyl-2-[[2-(4-morpholinyl)-1-oxoethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| N'-[4-(dimethylamino)phenyl]-N-propyloxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-tert-butyl-2-[[(3-nitrophenyl)-oxomethyl]hydrazo]-2-oxoacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[2-(4-chlorophenoxy)-1-oxoethyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[2-(2,4-dichlorophenoxy)-1-oxopropyl]hydrazo]-N-(4-methoxyphenyl)-2-oxoacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-fluorophenyl)-2-oxo-4,10-dihydro-3H-pyrimido[1,2-a]benzimidazole-4-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[4-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-5-methyl-2-thiazolyl]-2-(4-morpholinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-(1-phenylethyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-(2-ethyl-1-piperidinyl)ethyl]-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 1-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-1-phenylethyl]-4-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(3-methyl-1-piperidinyl)-2-phenylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(1,3-benzodioxol-5-yl)-2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-(3-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[4-[2-(3,5-dimethoxyanilino)-2-oxoethyl]-1-piperazinyl]-N-(4-ethoxyphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(4-methoxyphenyl)-2-(N-methylanilino)-2-(6-nitro-1,3-benzodioxol-5-yl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[[2-[(2,5-dimethylphenyl)sulfonylamino]-1-oxoethyl]amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-decyl-N'-(2-pyridinyl)oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 3-(3-bromoanilino)-2-oxo-1H-indole-3-carbonitrile | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(1,3-benzothiazol-2-yl)-2-ethylsulfonyl-3,4-dihydro-1H-isoquinoline-3-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-cyclopentyl-2-(2,3-dihydroindol-1-yl)-2-(4-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(3-oxo-2,4-dihydroquinoxalin-1-yl)-2-phenyl-N-(4-propan-2-ylphenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[4-chloro-3-(dimethylsulfamoyl)phenyl]-2-[(phenylmethyl)amino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-2-(2-fluorophenyl)sulfonyl-3,4-dihydro-1H-isoquinoline-3-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-anilino-N-(4-methylphenyl)-2-phenylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-anilino-N-(3,5-dimethylphenyl)-2-phenylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-chloro-2-methylphenyl)-2-[3-(dimethylsulfamoyl)anilino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(5-chloro-2,4-dimethoxyanilino)-1-(4-ethyl-1-piperazinyl)-1-propanone | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-(2-chloro-4-methylanilino)-N-[3-(dimethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(2,5-difluorophenyl)-2-(1-pyrrolidinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(2-bromophenyl)-2-[5-(dimethylsulfamoyl)-2-(ethylamino)anilino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3-chloro-4-fluorophenyl)-2-[5-(dimethylsulfamoyl)-2-(ethylamino)anilino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(4-bromo-2-fluorophenyl)-2-(2,4-dimethoxyanilino)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| LSM-24595 | [no description available] | low | 0 | 0 | amino acid amide | |
| 5-carbamoyl-4-methyl-2-[[1-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[(4-chlorophenyl)methyl]-2-[[[(2-fluorophenyl)methyl-(phenylmethyl)amino]-sulfanylidenemethyl]amino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(1,3-benzodioxol-5-yl)-2-(3-methyl-1-piperidinyl)-2-phenylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-chloro-5-[ethyl(phenyl)sulfamoyl]phenyl]-2-[methyl-(1-methyl-4-piperidinyl)amino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 3,4-dihydro-1H-isoquinolin-2-yl-[1-(8-quinolinylsulfonyl)-2-pyrrolidinyl]methanone | [no description available] | low | 0 | 0 | amino acid amide | |
| 1-(4-tert-butylphenyl)sulfonyl-N-(2-pyridinylmethyl)-2-piperidinecarboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| (3S,3'aR,8'aS,8'bS)-5-ethyl-2'-(phenylmethyl)spiro[1H-indole-3,4'-3a,6,7,8,8a,8b-hexahydropyrrolo[3,4-a]pyrrolizine]-1',2,3'-trione | [no description available] | low | 0 | 0 | amino acid amide | |
| cefatrizine | [no description available] | low | 0 | 0 | amino acid amide; carboxylic acid; cephalosporin; phenols; semisynthetic derivative; triazoles | antibacterial drug; EC 2.7.11.20 (elongation factor 2 kinase) inhibitor |
| N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(3,4-dichlorophenyl)-2-[4-(1-piperidinylsulfonyl)-1-piperazinyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| iprovalicarb | [no description available] | low | 0 | 0 | amino acid amide; carbamate ester; valine derivative | |
| vildagliptin | [no description available] | low | 0 | 0 | amino acid amide | |
| (3aR,4S,9aR,9bS)-N,2-bis(4-chlorophenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazine-4-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| eluxadoline | [no description available] | low | 0 | 0 | amino acid amide; benzamides; imidazoles; L-phenylalanine derivative; methoxybenzoic acid | delta-opioid receptor antagonist; gastrointestinal drug; kappa-opioid receptor agonist; mu-opioid receptor agonist |
| gosogliptin | [no description available] | low | 0 | 0 | amino acid amide | |
| teneligliptin | [no description available] | low | 0 | 0 | amino acid amide | |
| Glycyl-H-1152 | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-cyclopentyl-2-phenylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-(3,4-dimethoxyphenyl)ethyl]-N'-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| aspartic acid beta-naphthylamide | [no description available] | low | 0 | 0 | amino acid amide; L-aspartic acid derivative; N-(2-naphthyl)carboxamide | chromogenic compound |
| (3aR,4S,9aR,9bS)-N-(4-chlorophenyl)-2-(4-fluorophenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazine-4-carboxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[[3-(4-nitrophenyl)sulfonyl-2-oxazolidinyl]methyl]-N'-(2-pyridinylmethyl)oxamide | [no description available] | low | 0 | 0 | amino acid amide | |
| Majusculamide AB | [no description available] | low | 0 | 0 | amino acid amide | metabolite |
| anagliptin | [no description available] | low | 0 | 0 | amino acid amide | |
| 1-(4-methyl-1-piperazinyl)-2-[[(1R,2S)-2-(4-phenylmethoxyphenyl)cyclopropyl]amino]ethanone | [no description available] | low | 0 | 0 | amino acid amide | |
| bactobolin | [no description available] | low | 0 | 0 | amino acid amide | |
| N-(1,3-benzodioxol-5-yl)-2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]-N-[2-(methylthio)phenyl]acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| 2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]-N-(3-fluorophenyl)acetamide | [no description available] | low | 0 | 0 | amino acid amide | |
| N-[2-(4-chlorophenyl)ethyl]-2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]acetamide | [no description available] | low | 0 | 0 | amino acid amide |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Inflammation | 0 | low | 1 | 0 |
| Innate Inflammatory Response | 0 | low | 1 | 0 |
| Malaria, Falciparum | 0 | low | 1 | 0 |
| Plasmodium falciparum Malaria | 0 | low | 1 | 0 |